Not licensed to dispense sterile compounds, and not licensed generally, in California, Nevada, New Jersey, North Carolina, Texas, Massachusetts, Mississippi, New Hampshire, West Virginia, or Delaware
Understanding the safety profile, monitoring requirements, and potential physiological interactions of these therapies is essential for anyone contemplating combined treatment
Following administration of a combined oral contraceptive (0.035 mg ethinyl estradiol and 0.25 mg norgestimate) in the presence of a single dose of tirzepatide 5 mg, mean Cmax of ethinyl estradiol, norgestimate, and norelgestromin was reduced by 59%,66%, and 55%, while mean AUC was reduced by 20%, 21%, and 23%, respectively
IT OFTEN IS NOT UNTIL 4 OR MORE WEEKS ON A DOSE OF 25 UNITS + THAT PATIENTS WILL START TO SEE A DECLINE IN WEIGHT
Whats the difference between Ozempic and Wegovy